Normalization of cardiac structure and function after regression of cardiac hypertrophy

G B Habib1, D L Mann, W A Zoghbi

  • 1Section of Cardiology, Veterans Affairs Medical Center, Methodist Hospital, Houston, TX 77030.

American Heart Journal
|August 1, 1994
PubMed

Insights

Antihypertensive treatment normalized left ventricular mass and improved systolic and diastolic function in hypertensive patients. This study confirms that reducing blood pressure effectively reverses cardiac changes, restoring normal heart function compared to healthy individuals.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Echocardiography

Background:

  • Left ventricular hypertrophy (LVH) is a common complication of hypertension.
  • The impact of LVH regression on cardiac function remains debated.
  • Previous studies lacked age-matched control groups for comparison.

Purpose of the Study:

  • To assess the effect of antihypertensive treatment on left ventricular mass, systolic function, and diastolic function.
  • To compare cardiac function in treated hypertensive patients with age-matched normotensive controls.
  • To investigate the influence of LVH regression on cardiac performance.

Main Methods:

  • Echocardiographic and Doppler studies were performed on 27 hypertensive patients before and up to 7 months after treatment.
  • 27 age-matched normotensive subjects served as controls.
  • Left ventricular mass, systolic function (shortening fraction vs. end-systolic wall stress), and diastolic filling dynamics were assessed.

Main Results:

  • Antihypertensive treatment significantly reduced diastolic blood pressure and left ventricular mass index within 3 months.
  • Left ventricular mass index normalized, becoming similar to control subjects.
  • Systolic function remained unchanged overall but improved in patients with initially depressed function.
  • Ventricular filling dynamics improved and normalized within 3 months, similar to controls.

Conclusions:

  • Sustained hemodynamic unloading normalizes left ventricular mass in hypertensive patients.
  • Antihypertensive therapy improves both systolic and diastolic ventricular function.
  • Cardiac function in treated hypertensive patients becomes comparable to age-matched controls.

Related Concept Videos

Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...